HAWTHORNE, N.Y.--(BUSINESS WIRE)--Aug 2, 2018--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180802005744/en/

CONTACT: Taro Pharmaceutical Industries Ltd.

Mariano A. Balaguer

VP, CFO

914-345-9001

Mariano.Balaguer@taro.com

or

William J. Coote

AVP, Business Finance, Treasurer and Investor Relations

914-345-9001

William.Coote@taro.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH

SOURCE: Taro Pharmaceutical Industries Ltd.

Copyright Business Wire 2018.

PUB: 08/02/2018 01:44 PM/DISC: 08/02/2018 01:44 PM

http://www.businesswire.com/news/home/20180802005744/en